Pharma Phorum

JANUARY 27, 2023

AstraZeneca’s revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against most subvariants now circulating in the US.

Chemotherapy 135

Chemotherapy Immunization FDA Vaccines 135

Fierce Healthcare

JANUARY 27, 2023

SDOH startup Spatially Health partners with Florida ACO amid new CMS rules on equity agliadkovskaya Fri, 01/27/2023 - 13:40

130

130

Pharma Phorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds.

Vaccines 111

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 111

Pharmafile

JANUARY 27, 2023

The FDA is calling on the US Congress to work with them on a new regulatory pathway for cannabidiol (CBD). CBD is the non-psychoactive ingredient from the cannabis plant generally considered to have wellness properties.

FDA 88

FDA Communication 88

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

Dosage

Pharma Phorum

JANUARY 27, 2023

Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients out of “at least $100 million.”

Specialty Pharmacies 105

Specialty Pharmacies Insurance Health Insurance Companies Documentation 105

Pharmacy Times

JANUARY 27, 2023

The FDA has approved elacestrant (Orserdu) for the treatment of postmenopausal women or adult men with estrogen receptor–positive (ER+), HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least 1 line of endocrine therapy.

FDA 123

FDA 123

Pharmacy Times

JANUARY 27, 2023

The FDA has approved pirtobrutinib (Jaypirca) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma following at least 2 lines of systemic therapy, including a Bruton tyrosine kinase inhibitor.

FDA 123

FDA 123

Pharma Phorum

JANUARY 27, 2023

As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.

Packaging 105

Packaging Vaccines 105

Fierce Healthcare

JANUARY 27, 2023

Majority of patients repeatedly provide duplicate health information, Carta Healthcare survey finds aburky Fri, 01/27/2023 - 16:21

122

122

Pharma Phorum

JANUARY 27, 2023

Ipsen has suffered rather a setback in its marathon effort to bring palovarotene to market for ultra rare disease fibrodysplasia ossificans progressiva (FOP), after EU advisors recommended against approval.

FDA 98

FDA 98

Fierce Healthcare

JANUARY 27, 2023

Cigna sues CVS, former exec Amy Bricker over noncompete agreement pminemyer Fri, 01/27/2023 - 12:20

119

119

Fierce Pharma

JANUARY 27, 2023

With FDA approval for Jaypirca, Eli Lilly introduces new BTK blood cancer drug aliu Fri, 01/27/2023 - 15:29

FDA 111

FDA 111

Fierce Healthcare

JANUARY 27, 2023

FDA panel approves path toward one-shot yearly COVID vaccine fdiamond Fri, 01/27/2023 - 09:17

Vaccines 119

Vaccines FDA 119

Fierce Pharma

JANUARY 27, 2023

Time to shine, biosims: Amgen's Amjevita readies long-awaited assault on AbbVie's Humira zbecker Fri, 01/27/2023 - 11:50

94

94

Fierce Healthcare

JANUARY 27, 2023

Senators introduced bills to reform PBMs after stalling out in last Congress rking Fri, 01/27/2023 - 15:23

116

116

Pharmaceutical Technology

JANUARY 27, 2023

The European Union (EU) has granted approval for Daiichi Sankyo and AstraZeneca ’s Enhertu (trastuzumab deruxtecan) as monotherapy to treat unresectable or metastatic HER2 low (IHC 1+ or IHC 2+/ISH-) breast cancer adult patients.

Chemotherapy 94

Chemotherapy 94

Fierce Healthcare

JANUARY 27, 2023

HCA Healthcare closes out 2022 with revenue gains, lingering capacity constraints dmuoio Fri, 01/27/2023 - 12:42

116

116

Fierce Pharma

JANUARY 27, 2023

J&J, Legend's Carvykti hits goal in earlier myeloma, escalates CAR-T showdown with Bristol Myers' Abecma aliu Fri, 01/27/2023 - 11:02

86

86

Fierce Healthcare

JANUARY 27, 2023

I cry and no one cares': Medscape survey shows doctor burnout, depression is getting worse agliadkovskaya Fri, 01/27/2023 - 15:35

111

111

Fierce Pharma

JANUARY 27, 2023

FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data kdunleavy Fri, 01/27/2023 - 10:01

Vaccines 85

Vaccines FDA 85

Fierce Healthcare

JANUARY 27, 2023

CVS Health launches initiative with Meharry Medical College, Sinai Chicago aiming to reduce disparities in marginalized communities agliadkovskaya Fri, 01/27/2023 - 12:25

105

105

Pharma Phorum

JANUARY 27, 2023

pharmaphorum editor-in-chief Jonah Comstock joins Adi Hoess, CEO of Affimed Therapeutics, at their JPM2023 headquarters at the Zeppelin Hotel, to learn about Affimed’s work and their plans for the year to come.

Immunization 59

Immunization 59

Fierce Healthcare

JANUARY 27, 2023

Pearl Health clinches $75M backed by a16z to scale up value-based care tech hlandi Fri, 01/27/2023 - 17:00

105

105

European Pharmaceutical Review

JANUARY 27, 2023

The UK will be the first country to introduce a tailored framework for the regulation of innovative medicines manufactured at the point where a patient receives care, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced.

Hospitals 82

Hospitals 82

Fierce Healthcare

JANUARY 27, 2023

Kaiser Permanente earmarks $25M for gun violence prevention research, collaboration dmuoio Fri, 01/27/2023 - 09:34

98

98

European Pharmaceutical Review

JANUARY 27, 2023

To help expand access to medicines in low- and middle-income countries (LICs) Eli Lilly and Company has announced it will provide $1.15m to a new cold chain capacity initiative.

Communication 81

Communication 81

Fierce Pharma

JANUARY 27, 2023

The last to fall: FDA nixes emergency nod on AstraZeneca's COVID-19 antibody Evusheld fkansteiner Fri, 01/27/2023 - 09:38

FDA 79

FDA 79

Pharmaceutical Commerce

JANUARY 27, 2023

Complex to develop cGMP-compliant, commercial-scale plasmid DNA.

52

52

Fierce Pharma

JANUARY 27, 2023

Chiesi fills CEO post with Baxter veteran Accogli after acquiring Amryt in $1.5B deal kdunleavy Fri, 01/27/2023 - 15:07

76

76

Pharmaceutical Commerce

JANUARY 27, 2023

A breakdown of how the industry is using these lessons to move full steam ahead.

52

52

Pharma Phorum

JANUARY 27, 2023

Cost-effectiveness modelling is a powerful tool in understanding the value health interventions can bring to populations.

Vaccines 52

Vaccines 52

Pharmafile

JANUARY 27, 2023

Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the Committee for Medicinal Products for Human Use (CHMP) of the EMA for their drug palovarotene. read more Research and Development

52

52

Pharma Phorum

JANUARY 27, 2023

A study by UK researchers has found that buying patterns for over-the-counter (OTC) medicines for pain and indigestion, recorded using a store loyalty card, could be used to pick up early symptoms of ovarian cancer.

Medical Schools 52

Medical Schools 52

Pharmafile

JANUARY 27, 2023

The FDA has revoked its approval of AstraZeneca’s Evusheld due to the fact that it is not effective against more than 90% of COVID-19 variants currently in circulation in the US.

Chemotherapy 52

Chemotherapy Immunization FDA Communication 52

Pharma Phorum

JANUARY 27, 2023

The UK BioIndustry Association (BIA) and data and insights company Clarivate have released their annual UK Biotech Financing report – and, on the whole, the findings are not positive.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JANUARY 27, 2023

A single dose of monoclonal antibody (mAb) CIS43LS provided high levels of protection against malaria in a challenge study , according to new research.

Dosage 70

Dosage Vaccines 70